{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal Cartistem",
            "NStudiesAvail": 430108,
            "NStudiesFound": 6,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 6,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "The purpose of this study is to evaluate the safety and efficacy of adding allogenic umbilical cord blood-derived stem cell product(Cartistem\u00ae) on currently standard treatment of arthroscopic curettage and microfracture for osteochondral lesion of talus."
                        ],
                        "BriefTitle": [
                              "Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2015"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Osteochondral Lesion of Talus"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [],
                        "NCTId": [
                              "NCT02338375"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "The purpose of this study is to determine whether CARTISTEM, a cell therapeutic product, is safe and effective in the treatment of articular cartilage defects of the knee as a result of ageing, trauma, or degenerative diseases."
                        ],
                        "BriefTitle": [
                              "Evaluation of Safety and Exploratory Efficacy of CARTISTEM\u00ae, a Cell Therapy Product for Articular Cartilage Defects"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "August 29, 2017"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Degeneration Articular Cartilage Knee"
                        ],
                        "ConditionAncestorId": [
                              "D000009140",
                              "D000003240"
                        ],
                        "ConditionAncestorTerm": [
                              "Musculoskeletal Diseases",
                              "Connective Tissue Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC05",
                              "All",
                              "BC17"
                        ],
                        "NCTId": [
                              "NCT01733186"
                        ]
                  },
                  {
                        "Rank": 3,
                        "BriefSummary": [
                              "The purpose of the study is to assess and compare the safety and efficacy of the allogeneic-unrelated umbilical cord blood-derived mesenchymal stem cell product (Cartistem\u00ae) to that of a microfracture treatment in patients with articular cartilage defect or injury."
                        ],
                        "BriefTitle": [
                              "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "January 2011"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Cartilage Injury",
                              "Osteoarthritis"
                        ],
                        "ConditionAncestorId": [
                              "D000001168",
                              "D000007592",
                              "D000009140",
                              "D000012216",
                              "D000050723"
                        ],
                        "ConditionAncestorTerm": [
                              "Arthritis",
                              "Joint Diseases",
                              "Musculoskeletal Diseases",
                              "Rheumatic Diseases",
                              "Fractures, Bone"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC05",
                              "All",
                              "BC26",
                              "BC17"
                        ],
                        "NCTId": [
                              "NCT01041001"
                        ]
                  },
                  {
                        "Rank": 4,
                        "BriefSummary": [
                              "This is a long term follow-up study to investigate the safety and efficacy of CARTISTEM\u00ae, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture. Subjects who participated in and completed the Phase III trial (NCT01041001) will be tracked until the 60 month post-treatment timepoint."
                        ],
                        "BriefTitle": [
                              "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "INDUSTRY"
                        ],
                        "CollaboratorName": [
                              "Dong-A Pharmaceutical Co., Ltd."
                        ],
                        "CompletionDate": [
                              "May 2015"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Degenerative Osteoarthritis",
                              "Defect of Articular Cartilage"
                        ],
                        "ConditionAncestorId": [
                              "D000001168",
                              "D000007592",
                              "D000009140",
                              "D000012216",
                              "D000050723",
                              "D000014947"
                        ],
                        "ConditionAncestorTerm": [
                              "Arthritis",
                              "Joint Diseases",
                              "Musculoskeletal Diseases",
                              "Rheumatic Diseases",
                              "Fractures, Bone",
                              "Wounds and Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC05",
                              "All",
                              "BC26",
                              "BC17"
                        ],
                        "NCTId": [
                              "NCT01626677"
                        ]
                  },
                  {
                        "Rank": 5,
                        "BriefSummary": [
                              "Purpose:Development of novel strategy for treatment of anterior cruciate ligament (ACL) injury using stem cell."
                        ],
                        "BriefTitle": [
                              "Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 1, 2018"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Deficiency of Anterior Cruciate Ligament"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [],
                        "NCTId": [
                              "NCT02755376"
                        ]
                  },
                  {
                        "Rank": 6,
                        "BriefSummary": [
                              "The purpose of this study is to evaluate the efficacy and safety of adding CARTISTEM\u00ae(allogenic umbilical cord blood-derived stem cell product) on microfracture, a currently standard treatment for OLT, in patients with talar chondral or osteochondral defect."
                        ],
                        "BriefTitle": [
                              "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "INDUSTRY"
                        ],
                        "CollaboratorName": [
                              "Medipost Co Ltd."
                        ],
                        "CompletionDate": [
                              "June 13, 2022"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Chondral or Osteochondral Lesion of Talus"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [],
                        "NCTId": [
                              "NCT04310215"
                        ]
                  }
            ]
      }
}